| Literature DB >> 35408605 |
Ozlem Sevik Kilicaslan1,2, Sylvian Cretton1,2, Luis Quirós-Guerrero1,2, Merveilles A Bella3, Marcel Kaiser4,5, Pascal Mäser4,5, Joseph T Ndongo3, Muriel Cuendet1,2.
Abstract
Species of the genus Pleiocarpa are used in traditional medicine against fever and malaria. The present study focuses on the isolation and identification of bioactive compounds from P. bicarpellata extracts, and the evaluation of their antiprotozoal activity. Fractionation and isolation combined to LC-HRMS/MS-based dereplication provided 16 compounds: seven indole alkaloids, four indoline alkaloids, two secoiridoid glycosides, two iridoid glycosides, and one phenolic glucoside. One of the quaternary indole alkaloids (7) and one indoline alkaloid (15) have never been reported before. Their structures were elucidated by analysis of spectroscopic data, including 1D and 2D NMR experiments, UV, IR, and HRESIMS data. The absolute configurations were determined by comparison of the experimental and calculated ECD data. The extracts and isolated compounds were evaluated for their antiprotozoal activity towards Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania donovani, and Plasmodium falciparum, as well as for their cytotoxicity against rat skeletal myoblast L6 cells. The dichloromethane/methanol (1:1) root extract showed strong activity against P. falciparum (IC50 value of 3.5 µg/mL). Among the compounds isolated, tubotaiwine (13) displayed the most significant antiplasmodial activity with an IC50 value of 8.5 µM and a selectivity index of 23.4. Therefore, P. bicarpallata extract can be considered as a source of indole alkaloids with antiplasmodial activity.Entities:
Keywords: Pleiocarpa; alkaloids; antiprotozoal activity; dereplication; malaria
Mesh:
Substances:
Year: 2022 PMID: 35408605 PMCID: PMC9000413 DOI: 10.3390/molecules27072200
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Antiparasitic activity and cytotoxicity of extracts and compounds from P. bicarpellata.
| Sample | Plant Extract | IC50 a (µM) | SI c | ||
|---|---|---|---|---|---|
|
|
| Cytotoxicity b | |||
| Root | Methanol: dichloromethane | >50 | 3.5 d | >100 d | |
| Stem | Methanol | >50 | 34.2 d | >100 d | |
|
| >50 | 26.9 | 272.1 | 10.1 | |
|
| >50 | 26.6 | 155.5 | 5.8 | |
|
| >50 | 8.5 | 197.4 | 23.2 | |
|
| 25.3 | >50 | 293.7 | 11.6 | |
| Miltefosine | 0.554 | ||||
| Chloroquine | 0.006 | ||||
| Podophyllotoxin | 0.027 | ||||
a The IC50 are the means of two independent assays. b Rat skeletal myoblast (L6 cells). c Selectivity index (SI) = IC50 cytotoxicity/IC50 against parasite. d IC50 values expressed in µg/mL.
Figure 1Structures of the isolated compounds from Pleiocarpa bicarpellata.
1H-NMR (DMSO-d6, 600 MHz) and 13C-NMR (DMSO-d6, 150 MHz) data of compounds 7 and 15.
| Position | 7 | 15 | ||
|---|---|---|---|---|
| δH ( | δC, Type | δH ( | δC, Type | |
| 2 | 128.5, C | 176.1, C | ||
| 3 | 4.66, m | 65.9, CH | 2.05, m | 42.9, CH2 |
| 5 | 3.49, sept (3.6) | 59.5, CH2 | 3.23, s | 53.5, CH2 |
| 6 | 3.13, m | 18.0, CH2 | 3.00, m | 46.6, CH2 |
| 7 | 105.4, C | 54.6, C | ||
| 8 | 126.8, C | 135.7, C | ||
| 9 | 7.51, d (7.7) | 119.1, CH | 7.34, d (7.5) | 120.8, CH |
| 10 | 7.08, t (7.1) | 120.7, CH | 6.93, td (7.4) | 122.6, CH |
| 11 | 7.18, t (7.1) | 123.5, CH | 7.18, td (7.7) | 129.6, CH |
| 12 | 7.38, d (7.9) | 112.4, CH | 6.98, d (7.9) | 111.7, CH |
| 13 | 138.3, C | 145.6, C | ||
| 14 | 2.28, m | 30.9, CH2 | 1.95, m | 27.9, CH2 |
| 15 | 3.23, m | 30.4, CH | 3.22, s | 31.2, CH |
| 16 | 1.42, h | 35.4, CH2 | 96.4, C | |
| 17 | 3.79 (m) | 59.6, CH2 | 169.2, C | |
| 18 | 1.82, d (6.8) | 13.4, CH3 | 0.75, t (7.2) | 11.4, CH3 |
| 19 | 5.97, q (6.9) | 132.0, CH | 0.92, m | 24.3, CH2 |
| 20 | 129.0, C | 2.05, m | 41.3, CH | |
| 21 | 3.69, d (12.7) | 63.8, CH2 | 4.40, s | 66.6, CH |
| NCH3 | 3.18, s | 48.8 | ||
| OCH3 | 3.79, s | 51.9, CH3 | ||
| NH | 8.57, s | |||
Figure 2Key COSY (black bold line) and HMBC (blue arrows) correlations of compounds 7 and 15.
Figure 33D structures and key ROEs correlations of compounds 7 and 15.
Figure 4Experimental and TDDFT simulated ECD spectra of compounds 7 (A) and 15 (B).